BU-NOT-SET

CONTACT US
ReciBioPharm Is Advancing xRNA Production
  • Biologics
xRNA
Insight
Navigating the complexities of pre-filled syringes for biologics
  • Drug product
  • Manufacturing
syringes
eBook
Unlocking the potential of mRNA with robust lyophilisation strategies
  • Drug product
  • Manufacturing
containers
Insight
Advanced Bio Is Advancing AAV Production
  • Biologics
Recipharm_AdvancedBio_Adeno associated virus
Insight
Advanced is advancing xRNA manufacturing
  • Biologics
Recipharm_AdvancedBio_lab
Insight
What are the innovations driving the future of sterile drug packaging?
  • Drug product
  • Manufacturing
containers for steriale drugs
Insight
Revolutionising gene editing with end-to-end CDMO services
  • Biologics
GENE
Insight
Advanced Bio streamlines regulatory compliance
  • Biologics
DNA molecure
Insight
Advanced Bio leads nucleic acid innovation
  • Biologics
Recipharm_Advancedbio_nucleic acid
Insight
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field